Mtss Vs Allorisk Stratifier for Early Mortality Prediction after Allo-HCT in Myelofibrosis: Evidence from a Single-Center Treosulfan-Based Cohort

Key Points

• Early mortality prediction improves outcomes for individuals undergoing allo-HCT.
• The study reveals a significant difference in prediction accuracy between the Mtss and Allorisk stratifiers.
• Observational analysis using a cohort of myelofibrosis patients treated with treosulfan provides insights into mortality risks.
• Findings may influence clinical decisions, but caution is needed due to the single-center design.